I 

116TH CONGRESS 

2D SESSION H. R. 8121 

To require the Consumer Product Safety Commission to study the effect 

of the COVID–19 pandemic on injuries and deaths associated with consumer products, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

AUGUST 28, 2020 

Mr. CA ́RDENAS (for himself and Mr. RODNEY DAVIS of Illinois) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To require the Consumer Product Safety Commission to 

study the effect of the COVID–19 pandemic on injuries 

and deaths associated with consumer products, and for 

other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘COVID–19 Home 

5 Safety Act of 2020’’. 

6 SEC. 2. REPORT. 

7 (a) COVID-19 REPORT REQUIRED.—Not later than 

8 3 months after the date of the enactment of this section 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•HR 8121 IH

1 and every 3 months thereafter for the duration of the 

2 COVID–19 public health emergency, the Consumer Prod3 uct Safety Commission shall submit to the Committee on 

4 Energy and Commerce of the House of Representatives 

5 and the Committee on Commerce, Science, and Transpor6 tation of the Senate, and make publicly available, a report 

7 on the effect of the COVID–19 public health emergency 

8 on injuries and deaths from consumer products. 

9 (b) CONTENTS OF REPORT.—The report shall include 

10 the following: 

11 (1) Relevant data and statistics from— 

12 (A) the data sources of the Commission; 

13 (B) other appropriate agencies; 

14 (C) media reports; 

15 (D) poison control centers, to the extent 

16 practical; and 

17 (E) any other relevant data sources. 

18 (2) An identification of trends in injuries and 

19 deaths from consumer products, comparing data 

20 from representative time periods before and during 

21 the COVID–19 public health emergency. 

22 (3) An identification of subpopulations that 

23 have experienced elevated risk of injury or death 

24 from consumer products during the COVID–19 pubVerDate Sep 11 2014 22:19 Sep 04, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H8121.IH H8121

pbinns on DSKJLVW7X2PROD with BILLS
3 

•HR 8121 IH

1 lic health emergency, such as minorities, infants, 

2 people with disabilities, children, or the elderly. 

3 (4) An identification of where most injuries or 

4 deaths from consumer products during the COVID– 

5 19 public health emergency are taking place, such as 

6 the type of building or outdoor environment. 

7 (5) A specification about whether consumer 

8 products associated with a substantial number of in9 juries or deaths during the COVID–19 public health 

10 emergency are— 

11 (A) under recall; 

12 (B) subject to a voluntary consumer prod13 uct safety standard; or 

14 (C) subject to a mandatory consumer prod15 uct safety standard. 

16 (6) An identification of emerging consumer 

17 products that are posing new risks to consumers. 

18 (c) COVID–19 PUBLIC HEALTH EMERGENCY DE19 FINED.—The term ‘‘COVID–19 public health emergency’’ 

20 means a public health emergency declared pursuant to sec21 tion 319 of the Public Health Service Act (42 U.S.C. 

22 247d) as a result of confirmed cases of 2019 novel 

23 coronavirus (COVID–19), including any renewal thereof. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS